Neuroendocrine Tumors
Clinicopathological, Histomorphological and Immunohistochemical study of Neuroendocrine Tumors of GIT.
... Carcinoid syndrome is frequently discussed in relation to carcinoid tumors. Carcinoid syndrome found in 3 (4.1%) patients out of the 74 patients in a study conducted by Amarapurkar et al is very much comparable ...
115
Emerging use of everolimus in the treatment of neuroendocrine tumors
... Abstract: Neuroendocrine tumors (NETs) consist of a diverse family of malignan- cies, which are derived from neuroendocrine cells, most commonly originating from the gastroenteropancreatic (GEP) ...
10
123I-labeled metaiodobenzylguanidine for diagnosis of neuroendocrine tumors
... Neuroendocrine tumors (NETs) are a heterogeneous group of neoplasms originating from tissues derived from the neural crest, such as the adrenal medulla, the pituitary and the parathyroids, parafollicular ...
11
Everolimus and mTOR inhibition in pancreatic neuroendocrine tumors
... Pancreatic neuroendocrine tumors are rare and the majority of patients present in the advanced ...pancreatic neuroendocrine tumors have not significantly impeded tumor progression nor improved ...
8
Advances in the treatment of gastroenteropancreatic neuroendocrine tumors
... Gastroenteropancreatic neuroendocrine tumors (GEP-NETs) are a rare and hetero- geneous class of ...these tumors, their resistance to standard chemotherapy, and the excellent performance status of ...
8
Updates and management algorithm for neuroendocrine tumors of the uterine cervix
... neuroendocrine tumors. The authors found that 86% of neuroendocrine tumors had HPV ...of neuroendocrine tumors, HPV18 in 41%, and 4% of tumors were positive for other HPV ...
10
Clinicopathological features and surgical outcomes of neuroendocrine tumors of ampulla of Vater
... of neuroendocrine tumor occur, however, neuroendocrine tumor very rarely occurs at the ampulla of Vater ...[13]. Neuroendocrine tu- mors originating in the duodenum represent merely 4% of all ...
6
Profile of capecitabine/temozolomide combination in the treatment of well-differentiated neuroendocrine tumors
... 1907, neuroendocrine tumors (NETs) still represent a heterogeneous group of poorly understood rare malignancies with varying ...these tumors in the last 15 years accounting for ~ ...differentiated ...
6
Developmental trends in targeted radionuclide therapy of neuroendocrine tumors
... Survival and response after peptide receptor radionuclide therapy with [ 90 Y-DOTA0,Tyr3]octreotide in patients with advanced gastroenteropancreatic neuroendocrine tumors. Semin Nucl[r] ...
6
The genomic landscape of small intestine neuroendocrine tumors
... All tumors were well differentiated according to the original pathology report, as confirmed by review of newly prepared frozen sections (Figure ...of tumors, categorizing these as well-differentiated (G1) ...
8
Clinicopathological characteristics and molecular abnormalities of primary grade 2 neuroendocrine tumors of the cervix
... 2 tumors of our three cases were stud- ...2 neuroendocrine tumors have not been reported ...cell neuroendocrine carcinoma of the uterine cervix in 10 cases and found the mutations of the gene ...
8
Neuroendocrine tumors of the gallbladder: a case report and review of the literature
... Carcinoids are rare neuroendocrine tumors (NETs) derived from enterochromaffin or Kulchitsky cells, which are widely distributed in the body [1,2]. Conse- quently, NETs can be found in any location of the ...
5
Role of Immunohistochemical Studies in Neuroendocrine Tumors of Gastrointestinal Tract.
... differentiated neuroendocrine tumors occurring within the gastrointestinal tract have their location in the appendix followed by small intestine, rectum and ...
66
Appendicular Neuroendocrine Tumors in Children
... Appendicular Neuroendocrine Tumors (ANETs) in pediatric age group are ...these tumors are incidentally picked up during routine histological examination of resected ...
7
Original Article SATB2 is a sensitive marker for lower gastrointestinal well-differentiated neuroendocrine tumors
... well-differentiated neuroendocrine tumors to explore its potential as a diagnostic marker for hindgut well-differentiated neuroendocrine ...well-differentiated neuroendocrine tumors of ...
11
Pan, Jie (2013): Molecularly targeted therapy on a new preclinical mouse model for gastric neuroendocrine tumors. Dissertation, LMU München: Medizinische Fakultät
... low-grade neuroendocrine tumors 65 , and a high expression of PDGFRA was significantly correlated with shorter patients’ survival and could serve as a prognostic marker 66 ...pancreatic ...
144
Expression of transcription factors in MEN1-associated pancreatic neuroendocrine tumors
... MEN1-associated pancreatic neuroendocrine tumors (pNETs) may potentially express distinct hormones, but the mechanism has not been elucidated. Transcription factors such as MafA and Pdx1 have been ...
6
The NETPET Score: Combining FDG and Somatostatin Receptor Imaging for Optimal Management of Patients with Metastatic Well-Differentiated Neuroendocrine Tumors
... Neuroendocrine tumors (NET) are often metastatic at the time of diagnosis. Metastatic well-differentiated (G1/G2) NET may display a wide range of behaviors, ranging from indolent to aggressive, even within ...
5
Original Article Safety and tolerability of sequencing somatostatin analogs (octreotide to lanreotide depot) in the treatment of neuroendocrine tumors: an institutional case series
... In NeuroEndocrine Tumors (CLARINET), established lanreotide depot as the first Food and Drug Administration-approved synthetic somatosta- tin analog (SSA) for treatment of patients with well or moderately ...
7
Neuroendocrine tumors presenting with thyroid gland metastasis: a case series
... growing tumors, a relatively longer survival is still possible, as observed in our first ...Aggressive tumors lead to painful thyroid nodules with rapid growth and local compression ...well-differentiated ...
5